TNFSF14 and COVID-19: Of note, the TNFSF14 is distinctively enhanced in the plasma of COVID-19–infected individuals but not in cases of other related pulmonary infections such as influenza (flu) virus and respiratory syncytial virus (RSV) (Fig. 3).